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The bactericidal effect of gentarrucin on Pseudomonas aerugwosa ATCC 27853 was
investigated in a computer controlled dynamic in-vitro model, which allows the
simultaneous simulation of three different dosing regimens for several days. The
same total dose reduced cfu-counts of Pseudomonas aerugmosa most effectively,
when administered with peak concentrations of 32 mg/1 every 32 h, whereas the
other dosing regimens with peak concentrations of 16 mg/1 every 16 h and 8 mg/1
every 8 h were distinctly less effective following the second and subsequent doses. It
was shown that the use of a microcomputer facilitates the in-vitro investigation of
multiple dosing regimens but counting of cfu cannot be substituted by automatic
measurements of turbidity when rapid bactericidal effects occur.
Introduction
With few exceptions, such as gonorrhoea or uncomplicated urinary tract infections, the
treatment of infectious diseases requires administration of antibiotics in multiple doses
for several days. It therefore seems appropriate to perform m-vitro investigations of
multiple dosing regimens which can yield important information concerning the
bactericidal or bactenostatic action of the second or subsequent doses and the
possibility of emerging resistance, phenomena which escape the m-vitro studies of
single doses.
The use of a microprocessor with the capacity to control simultaneously multiple
independent sets facilitates the performance of long-term experiments and improves
their reproducibility. The feedback of certain data to the computer offers additional
advantages such as (i) information concerning the actual state of the experiment by
displaying and recording turbidity data which can be used as a guideline for diluting
the samples for cfu-determinations and (li) maintenance of constant pharmacokinetic
conditions by verification of liquid levels.
Turbidity data can further be used to initiate automatically active intervention in an
experiment, e.g. when lack of action of a drug is detected
The purpose of the present study was to prove the feasibility of the computer controlled
in-vitro model to determine the effect of three different multiple dosing regimens of
gentamicin on the viable counts of Pseudomonas aeruginosa.
Materials and methods
Media
Mueller-Hinton broth (MHB) and Mueller-Hinton agar (MHA) were obtained from
Difco (Brunschwig AG, Basel, Switzerland). MHB was supplemented with Mg + + and
Ca + + (MHB-S) according to NCCLS standards (1983).
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Gentamicin laboratory reference powder was obtained from Schering (Essex Chemie,
Luzern, Switzerland).
Bacterial strain
Log-phase cultures of Ps. aeruginosa ATCC 27853 were photometrically adjusted by
diluting them with MHB-S to yield a final inoculum of 105 cfu/ml. Glass flasks
(volume 125 ml) were filled with 100 ml of the bacterial suspension. The minimal
inhibitory concentration (MIC) of gentamicin in MHB-S was 20 mg/1.
Viable counts of bacteria
To detect > 100 cfu/ml, three drops of 20 fi\, each from appropriate tubes of serial ten-
fold dilutions, were plated on MHA. Less than 100 cfu/ml were quantified by
membrane filtration of 1 ml and 10 ml of undiluted samples, yielding a sensitivity of
0-5 cfu/ml. Filters were washed with 100 ml of 0-9% NaCl in water to eliminate
residual drug and placed on MHA. Viable counts were not adjusted for the loss which
occurred through the dilution with drug free broth.
Simulation of multiple dosing regimens
The in-vitro model (designated apparatus model I) described by Grasso et al. (1978)
was modified by adding a second peristaltic pump which drained the culture flask and
thereby maintained a constant fluid level (Figure 1, pump 3). In addition, this pump
broth
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Figure 1. Single set of the in-ntro model. Pump speed of pump PI was adjusted to produce the desired
elimination half-life, whereas pump P3 (drain) was suctioning at a higher flow rate to maintain the constant
volume and to provide the ventilation of the head space with filtered air (pore size: 0-2 /an). Pump P2 was
operated according to the dosage regimens.
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control of three m-vitro sets
Figure 2. Diagram of the computer system The process interface was designed to control simultaneously
three m-vilro sets as shown in Figure 1
provided continuous ventilation of the head space of the culture flask through a port
for filtered air which allowed aerobic growth conditions. Three sets of the in-vitro model
were simultaneously operated in an incubator at a temperature of 370°C, simulating
three multiple dosing regimens (A, B and C) with identical total doses, which produced
peak gentamicin concentrations of 8, 16 and 32 mg/1 at dosage intervals of 8, 16 and
32 h, respectively. The infusion periods were 30 min each. Human one-compartment
pharmacokinetics with an elimination half-life of 2-2 h were simulated by continuous
dilution with drug free broth.
Turbidimetry
Three photometers were built with extra-bright light-emitting diodes, wave-length
660 nm (Stanley ESBR 5501, Dewald AG, Zurich, Switzerland), matched pairs of
photodiodes (United Detector Technology PIN-3DP, Traco AG, Zurich, Switzerland)
and a log ratio amplifier (LOG 100, Burr-Brown AG, Ruschlikon, Switzerland)
providing a compensated operation with a threshold for the detection of
> 200,000 cfu/ml. Turbidity was measured in each culture flask over a path length of
4-6 cm and recorded on the disc of the computer at 5 min intervals.
Computer control
An Apple II® plus computer (Apple Computer Inc., Cupertino, California), supplied
with a specially designed interface was used to control simultaneously three sets of the
in-vitro model as shown in Figure 2.
Results
Multiple dosing regimens
The gentamicin concentration versus time curves for the three different dosing
regimens are displayed in Figure 3. The resulting viable counts and optical density
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Figure 3. Concentration versus time curves of the three gentamian dosing regimens A, B and C with an
identical total dose yielding peak concentrations of 8, 16 and 32 mg/l at intervals of 8, 16 and 32 h,
respectively
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Figure 4. Cfu and turbidity versus time curves of Ps aeruginosa ATCC 27853, exposed to the three dosing
regimens of gentamian which are displayed in Figure 3 The photometers, operated at 660 nm, yielded a
threshold of the detection of > 200,000 cfu/ml
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versus time curves (Figure 4) show a rapid and dose dependent decline after the first
dose, followed by regrowth within 4 to 8 h. Apart from a slight reduction of cfu at
24 h, the subsequent doses of regimen A (8 mg/1 peak concentrations every 8 h) showed
no apparent bactericidal activity. The second and third dose of regimen B, yielding a
peak concentration of 16 mg/1 at 16 and 32 h were marginally effective, and at 48 h, the
effect of the fourth dose was completely lacking. This is in contrast to the obvious
bactericidal effect of the second dose of regimen C (32 mg/1 peak concentration) at 32 h
which resulted in a decrease of approximately 4 log cfu, comparable to the effect of the
first dose.
Turbidity versus time curves showed a good correlation with the cfu-counts when
growth occurred. In periods of rapid bactericidal action (e.g. regimen C at 32 h),
turbidity was determined by the washout of dead bacteria through dilution with drug
free broth and deviated markedly from the determinations of viable counts.
Discussion
The effect of multiple doses of gentamicin on Ps. aerugmosa ATCC 27853 was studied
in a computer controlled in-vitro model. It was demonstrated that identical total doses
of gentamicin were most effective, when administered at intervals of 32 h. Although the
concentration of gentamicin for that regimen (C) was below the MIC for
approximately 3/4 of the dosage interval, cfu's did not exceed the counts observed with
regimen A within the first 24 h. Indeed, the long period of subinhibitory concentrations
may be the reason for the retained bactericidal action of the second dose.
The on-line measurement of turbidity showed a good correlation with
> 200,000 cfu/ml as long as growth occurred and was very useful as a guideline for
diluting the samples for cfu-determinations. Due to insufficient sensitivity and the
inability to quantify rapid bactericidal effects, as observed with aminoglycosides, the
substitution of cfu-counts by turbidity measurements is not advisable.
The use of a microcomputer was a time-saving and reliable method to simulate
multiple dosing regimens for several days. Limitations in simultaneously performing
multiple dosing regimens were found to be the processing of samples, increasing
number of pumps and space in the incubator.
Further development of the model includes the analogue control of pump speeds to
simulate combination therapies of drugs with different half-lives and the automatic use
of turbidity data to evaluate optimal timing of synergistic combinations.
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